ARBNU M,WALKER A,MEIJER C J.HPV-based cervical-cancer screening in China[J]. Lancet Oncol,2010,11(12):1112-1113.
[2]
BURCHELL A N,WINER R L,DE SANJOSE S,et al.Chapter 6:Epidemiology and transmission dynamics of genital HPV infection[J].Vaccine,2006,24(S3):52-61.
[3]
MUNOZ N,BOSCH F X,DE SANJOSE S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348(6):518-527.
[4]
BRUNI L,DIAZ M,CASTELLSAGUE X,et al.Cervical human papillomavirus prevalence in 5 continents:meta-analysis of 1 million women with normal cytological findings[J]. J Infect Dis,2010, 202(12):1789-1799.
[5]
BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
[6]
CROW J M.HPV:the global burden[J]. Nature,2012,488:2-3.
HUANG S,AFONINA I,MILLER B A,et al.Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women[J]. Int J Cancer,1997,70(4):408-411.
[11]
LIU J,ROSE B,HUANG X,et al.Comparative analysis of characteristics of women with cervical cancer in high-versus low-incidence regions[J]. Gynecol Oncol,2004,94(3):803-810.
[12]
BALOCH Z,LI Y,YUAN T,et al.Epidemiologic characterization of human papillomavirus(HPV)infection in various regions of Yunnan Province of China[J]. BMC Infect Dis,2016,16(1):228.
[13]
TANG Y,ZHENG L,YANG S,et al.Epidemiology and genotype distribution of human papillomavirus(HPV)in Southwest China:a cross-sectional five years study in non-vaccinated women[J]. Virol J,2017,14(1):84.
[14]
AGENIS A,DUFIT V,DOUINE M,et al.High prevalence of HPV infection in the remote villages of French Guiana:an epidemiological study[J]. Epidemiol Infect,2017,145(6):1276-1284.